Toine Egberts

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands, Netherlands

Disclosure information not submitted.

Presentation(s):

• The nature of uncertainties on the benefit-risk balance of anticancer medicines at initial marketing authorisation in the European Union

  Monday, August 26, 2024
  2:30 PM – 2:45 PM CEST

• Leftover of amoxicillin suspension after use by children in the Netherlands

  Wednesday, August 28, 2024
  2:45 PM – 3:00 PM CEST